AU2023203618B2 — Transdermal formulation and delivery method of low solubility or unstable unionized neutral drugs by in situ salt-to-neutral drug conversion of salt drug
Assigned to Corium LLC · Expires 2025-09-18 · 1y expired
What this patent protects
#$%^&*AU2023203618B220250918.pdf##### ABSTRACT Compositions, devices, and methods for transdermal administration of active agents provided in their salt form instead of neutral form are provided. ABSTRACT Compositions, devices, and methods for transdermal administration of …
USPTO Abstract
#$%^&*AU2023203618B220250918.pdf##### ABSTRACT Compositions, devices, and methods for transdermal administration of active agents provided in their salt form instead of neutral form are provided. ABSTRACT Compositions, devices, and methods for transdermal administration of active agents provided 2023203618 09 Jun 2023 in their salt form instead of neutral form are provided.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.